Investment Q&A

• Savaria Corporation (SIS)
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Hi folks
I sold SIS at a loss in my non registered account. However I also own it in my TFSA and my RRIF at a gain. Does this make my loss null and void? I may buy it back in my non registered in 30 days. Also you had mentioned that you would like to see SIS break at $14.15... But is it good to buy now (if I decide to add to my TFSA holding).? Or would that also break the 30 day rule?
Thank you again for a good year.

Upvote 0

Read Answer Asked by El-ann on November 27, 2019

• iShares U.S. Medical Devices ETF (IHI)
  • View IHI Profile
  • View Questions on IHI

Q: Hi Peter, Ryan, and Team,
We needed to increase our Healthcare exposure, and neglected to consider tax implications when buying IHI:US in a non-registered account. Will this 'mistake' significantly complicate our tax return, and will we get back the withholding tax? Your insight is appreciated.

Upvote 0

Read Answer Asked by Jerry on November 26, 2019

• CRH Medical Corporation (CRH)
  • View CRH Profile
  • View Questions on CRH
• WELL Health Technologies Corp. (WELL)
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: For a minimum 3 year hold which would you prefer,crh or well?

Upvote 0

Read Answer Asked by Maurice on November 26, 2019

• Zymeworks Inc. (ZYME)
  • View ZYME Profile
  • View Questions on ZYME

Q: whats your opinion on zymeworks.i have owned it since 15., its doubled;
its results are strong, they have relationships with 8 of the largest pharma companies. It keeps hitting new 52 week highs. i know they will do a fund raise soon, but got thru the last fund raise with ease. . dave

Upvote 0

Read Answer Asked by david on November 25, 2019

• Celgene Corporation (CELG)
  • View CELG Profile
  • View Questions on CELG
• Bristol-Myers Squibb Company (BMY)
  • View BMY Profile
  • View Questions on BMY

Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?

Thanks, Michael

Upvote 0

Read Answer Asked by Michael on November 25, 2019

• Knight Therapeutics Inc. (GUD)
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Yesterday they announced the end of the relationship with Medison . However they ignored the deal with Onconova ONTX.
ONTX had a press release but GUD ignored it.
On Sedar the Medison news is posted but not ONTX. Any insight as to why ? Too small a deal perhaps ?
Thanks

Upvote 0

Read Answer Asked by Luc on November 22, 2019

• Guardant Health Inc. (GH)
  • View GH Profile
  • View Questions on GH

Q: Peter and staff; I have held this stock for a short period of time and it has not produced the results I was looking for. Can you share an opinion and possibly a suggestion going forward?

Upvote 0

Read Answer Asked by John on November 22, 2019

• AMN Healthcare Services Inc (AMN)
  • View AMN Profile
  • View Questions on AMN

Q: What do you think of AMN as a healthcare holding?

Upvote 0

Read Answer Asked by Kel on November 22, 2019

• Inspire Medical Systems Inc. (INSP)
  • View INSP Profile
  • View Questions on INSP

Q: Any thoughts on this medical device company?
Offers an FDA approved alternative for those dealing with sleep apnea.

Upvote 0

Read Answer Asked by Wendy on November 21, 2019

• InMode Ltd. (INMD)
  • View INMD Profile
  • View Questions on INMD

Q: any idea why stock is down on big volume?

Upvote 0

Read Answer Asked by hal on November 21, 2019

• BioSyent Inc. (RX)
  • View RX Profile
  • View Questions on RX
• HLS Therapeutics Inc. (HLS)
  • View HLS Profile
  • View Questions on HLS

Q: your thoughts on recent Q3 results. worth sticking with this company or can you suggest alternative investment.
thanks
Don

Upvote 0

Read Answer Asked by Don on November 21, 2019

Q: Hello 5i , could I have your comments on Kodiak Sciences.
Its momentum is amazing. Any red flags?
Thanks
Dave

Upvote 0

Read Answer Asked by Dave on November 21, 2019

• Amarin Corporation plc (AMRN)
  • View AMRN Profile
  • View Questions on AMRN

Q: Hi 5i Team,

Today analyst at Oppenheimer issues a report which commented a very bearish take on Amarin
Corp stock , arguing it will fall to 7.00 within 18 months due to higher cost in sale. This resulted a 15% drop at time of writing.

I am holding this stock for a few months , should I hold , sell or buy more?

What is your take? Are you still positive on this stock?

Thank you for your professional advice and assistance as always.







arguing

Upvote 0

Read Answer Asked by Pui on November 20, 2019

• Medtronic plc. (MDT)
  • View MDT Profile
  • View Questions on MDT

Q: mdt reported today your thoughts please Gary

Upvote 0

Read Answer Asked by gary on November 20, 2019

• Akumin Inc. (AKU)
  • View AKU Profile
  • View Questions on AKU

Q: Hello, A couple of well-respected advisors have recently recommended this stock on BNN Market Place. I read your opinion on this stock in October which was not positive. Has your opinion changed?

Upvote 0

Read Answer Asked by Alan on November 19, 2019

• BELLUS Health Inc. (BLU)
  • View BLU Profile
  • View Questions on BLU

Q: Hi 5i Team,
Your comment on Bellus Health’s earning and it’s future outlook please.

Thank you for your professional service and advice as always.

Upvote 0

Read Answer Asked by Pui on November 18, 2019

• Knight Therapeutics Inc. (GUD)
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Does GUD's precipitous drop in share price indicate that the market believes the acquisition of Biotoscana was not a good investment? How solid is Biotoscana? Are some of their products fit for the US/CDN markets? South American market? Your opinion is always appreciated. Thanks. Gaston

Upvote 0

Read Answer Asked by Gaston on November 18, 2019

• Intuitive Surgical Inc. (ISRG)
  • View ISRG Profile
  • View Questions on ISRG

Q: I know you have liked this stock in the past. It has been relatively flat over the last year (bouncing up and down) How do you feel about it now and going forward? Is there a better risk/reward trade off in the space?

Thanks!

Upvote 0

Read Answer Asked by Steve on November 15, 2019

• NextCure Inc. (NXTC)
  • View NXTC Profile
  • View Questions on NXTC

Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.

Upvote 0

Read Answer Asked by Vinod on November 15, 2019

• Amarin Corporation plc (AMRN)
  • View AMRN Profile
  • View Questions on AMRN

Q: Hi 5i team,

Back to AMRN. I thought they hit a home run yesterday with a unanimous (16 to 0) vote of the Advisory Committee to approve an expanded label use of Vascepa for treating various heart-related conditions, which should give them access to a much larger patient population base. However, the market is not so sure as the response is very muted at least so far today, and that may change. I took a small position to manage risk as I expected a big move one way or the other. I recognize this still has to go to the full FDA in a few weeks, but I understand that the FDA seldom overturns a strong endorsement of the AdCom. Am I missing something here in the muted market response?

Thanks again.
Dave

Upvote 0

Read Answer Asked by Dave on November 15, 2019